Immunohistochemistry as a Screening Tool for FISH Testing in the Diagnosis of Double Hit Lymphoma

Emile Sansakda-Phillips1, Emma-li Yit1, Fiona Webb1, Maya Latimer2,3, Adrienne Morey3,4, Dipti Talaulikar2,3

1 Cytogenetics department, The Canberra Hospital, PO Box 11, Woden, ACT, 2606
2 Haematology department, The Canberra Hospital, PO Box 11, Woden, ACT, 2606
3 The Australian National University, Acton, ACT, 2601
4 Anatomical Pathology department, The Canberra Hospital, PO Box 11, Woden, ACT, 2606

 

Background: Double hit lymphoma (DHL) is a subtype of diffuse large B-cell lymphoma (DLBCL) characterised by the presence of c-MYC and BCL2 and/or MYC and BCL6 gene rearrangements on Fluorescence in-situ Hybridisation (FISH). Double expressor lymphomas (DEL) are DLBCL cases with high expression of MYC and BCL2 proteins on immunohistochemistry (IHC). DHL and DEL are associated with a poor outcome with DEL being associated with a less adverse outcome.

Aims: Given the high cost of FISH testing to establish a diagnosis of DHL, and the lack of definitive guidelines for selecting cases for FISH, we conducted this study to determine whether c-MYC IHC could be used as a screening tool. Our second aim was to determine whether FISH analysis could be reliably performed on tissue sections.

Methods: Laboratory data on IHC and FISH tests performed on DLBCL (n=14) and Burkitt lymphoma (BL) (n=1) cases between 2015 and 2016 was extracted and analysed. A     cut-off value of 40% was used to determine positivity on IHC for c-MYC. FISH studies were performed in-house (on fresh or Formalin Fixed Paraffin Embedded (FFPE) tissue sections) (n=13) or as sendaways (n=2).

Results: 7 cases of DLBCL were diagnosed to be DEL. Of these, the average expression was 67% for c-MYC. BCL2 expression was positive in 14 cases (quantitative data was not available). FISH for c-MYC was positive in 6 cases including one case of BL. FISH for BCL2 was positive in 8 cases with 3 cases being DHL and 1 THL. All 4 cases were DEL.

Overall, 11 cases were tested using FFPE tissue with reportable results obtained for all cases.

 

Conclusion: In our laboratory, c-MYC IHC appears to be a good screening tool and FPPE is a feasible method for FISH analysis for DHL. A more substantial data set is being curated to expand the cohort.

 

 


Biography

Scientists from the cytogenetics department in ACT Pathology, The Canberra Hospital

About conferences.com.au

conferences.com.au provides delegate registration, website and app solutions, and financial management for conferences, conventions and scientific meetings.

Terms & Conditions

All registrations and bookings are subject to our standard term and conditions.

Contact Us

Please contact the team at conferences.com.au with any questions regarding the conference.
© 2017 - 2020 Conference Design Pty Ltd. conferences.com.au is a division of Conference Design Pty Ltd.